Terrill K. McClanahan
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Psoriasis: Treatment and Pathogenesis, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, T-cell and B-cell Immunology
Most-Cited Works
- → IL-23 drives a pathogenic T cell population that induces autoimmune inflammation(2005)4,029 cited
- → IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade(2017)3,762 cited
- → Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy(2018)2,281 cited
- → Development, cytokine profile and function of human interleukin 17–producing helper T cells(2007)2,001 cited
- → Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial(2016)1,717 cited
- → Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation(2003)1,633 cited
- →